Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Non-cash Items (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Non-cash Items for 8 consecutive years, with $9.7 million as the latest value for Q1 2025.

  • Quarterly Non-cash Items fell 28.68% to $9.7 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $9.7 million through Mar 2025, down 28.68% year-over-year, with the annual reading at $248617.0 for FY2024, 11.48% up from the prior year.
  • Non-cash Items for Q1 2025 was $9.7 million at Precision Biosciences, up from $248617.0 in the prior quarter.
  • The five-year high for Non-cash Items was $44.3 million in Q2 2021, with the low at $176113.0 in Q4 2022.
  • Average Non-cash Items over 5 years is $21.3 million, with a median of $20.2 million recorded in 2023.
  • Peak annual rise in Non-cash Items hit 59.41% in 2022, while the deepest fall reached 96.36% in 2022.
  • Over 5 years, Non-cash Items stood at $4.8 million in 2021, then plummeted by 96.36% to $176113.0 in 2022, then rose by 26.63% to $223019.0 in 2023, then rose by 11.48% to $248617.0 in 2024, then skyrocketed by 3801.58% to $9.7 million in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $9.7 million, $248617.0, and $16.7 million for Q1 2025, Q4 2024, and Q3 2024 respectively.